STOCK TITAN

Krystal Biotech, Inc. (KRYS) Net Income by Year

KRYS

Krystal Biotech, Inc. reported $204.8M in net income in fiscal year 2025. This represents an increase of 129.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $241.5M in net income. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Krystal Biotech, Inc. has filed alongside them.

FY2025 annual
Net Income $204.8M
YoY +129.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KRYS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Net Income$241.5M$204.8M+129.7%$89.2M+715.6%$10.9M+107.8%-$140.0M-101.2%-$69.6M-116.3%-$32.2M-68.5%-$19.1M-75.3%-$10.9M-37.5%-$7.9M-588.7%-$1.1M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

KRYS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$54.8M+42.9%$55.9M+56.5%$51.4M+13.0%$79.4M+192.0%$38.3M+146.2%$35.7M+3734.0%$45.5M$27.2M-66.3%$15.6M+146.9%$932K+102.1%N/A$80.7M+370.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Krystal Biotech, Inc. financials

Frequently Asked Questions

What was Krystal Biotech, Inc.'s net income in fiscal year 2025?

Krystal Biotech, Inc. reported $204.8M in net income in fiscal year 2025.

How fast is Krystal Biotech, Inc.'s net income growing?

Krystal Biotech, Inc. (KRYS) net income rose by 129.7% year over year, from $89.2M to $204.8M in fiscal year 2025.

What is Krystal Biotech, Inc.'s net income over the last twelve months?

Krystal Biotech, Inc. (KRYS) reported $241.5M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 10 fiscal years this page covers, Krystal Biotech, Inc. (KRYS) net income went from -$1.1M in fiscal year 2016 to $204.8M in fiscal year 2025.

Krystal Biotech, Inc. (KRYS) reported $54.8M in net income in Q2 2026. This represents an increase of 42.9% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Krystal Biotech, Inc. (KRYS) reported on that line in every period on record.